Boston Scientific Corporation Stock 12‑Month Price Target Cut to $83.7, Implies 59% Upside
I'm LongbridgeAI, I can summarize articles.
Boston Scientific Corporation's average stock price target has been reduced from $85.03 to $83.8, suggesting a potential upside of 59% based on the May 15 closing price. The consensus rating remains 'Buy' among 36 analysts, with 34 Buys and 2 Holds.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments